Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 2Withdrawn 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Radiodermatitis 2Breast Neoplasms 2Dermatitis 1

Interventions

Trastuzumab 78Capecitabine 59Cyclophosphamide 54Paclitaxel 52Docetaxel 50Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 26exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Taxes 17Everolimus 17Epirubicin 15pertuzumab 13Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13palbociclib 12Magnetic Resonance Spectroscopy 12liposomal doxorubicin 11atezolizumab 11Filgrastim 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Petrolatum × Clear all
NCT03596073 2025-05-07

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

Massachusetts General Hospital

Phase 1 Terminated
43 enrolled
Breast

Breast Neoplasms

NCT02534129 2017-10-06

Topical Use of Difinsa53â„¢ to Prevent Radiation Dermatitis

ProTechSure Scientific, Inc.

Phase 1/2 Terminated
13 enrolled 3 charts
Breast

Breast Neoplasms, Dermatitis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡